US based biosimilars company Therapeutic Proteins International LLC (TPI) received the ‘Innovation of the Year’ award sponsored by Honeywell at the Global Generics and Biosimilars Awards held in Paris on 7 Oct 2014. The accolade recognized TPI’s significant accomplishments in biopharmaceutical manufacturing and continued commitment to innovation in the industry. Nominations for the award were collected internationally from both generic and biosimilar companies. The three finalists for the ‘Innovation of the Year’ award were Teva Sandoz and TPI. In addition to the area of innovation Generics Bulletin recognized companies in the generic and biosimilar industry for work in areas such as patent litigation API supply business development and acquisition among others.